After two years characterized by layoffs, pipeline reorganizations, FDA delays and clinical holds, Novavax CEO John Jacobs ...

According to the 6 industry analysts covering Novavax, the consensus is that breakeven is near. They anticipate the company to incur a final loss in 2024, before generating positive profits of US$82m ...

"Today, we announce the beginning of an exciting new chapter for Novavax with the launch of a strategically important partnership with one of the world's leading vaccine companies," NVAX CEO John ...

Donald Trump continues to make waves in biopharma; Sage rejects Biogen’s unsolicited takeover offer; the obesity space sees ...

Dynavax should take a leaf from its vaccine maker peer, Novavax, and work to monetize its CpG1018 adjuvant. Learn more about ...

A freshman Idaho lawmaker wants to ban most COVID-19 shots for the next decade, with a bill rooted in misconceptions about ...

Capstone Companies, Inc. (OTCQB: CAPC) announced today the appointment of Brian Rosen as a non-employee director, effective January 20, 2025.

Shares of vaccine companies fell after a Senate panel voted to advance Robert F. Kennedy Jr.'s nomination to lead the ...

Read Next: UnitedHealth CEO Highlights Hospitals ... the same mRNA technology used in the company's COVID-19 vaccine. Novavax, Inc. NVAX has a bird flu vaccine in clinical trials in addition ...

NFL makes multiyear commitment to playing regular season games in Melbourne; partners with the Victorian State Government and ...

Vaccines that use mRNA technology are not gene therapy, according to medical doctors, including retired physician Dr. David Pate, the former CEO of St ... vaccine made by Novavax does not.

Pfizer, Moderna and Novavax — the makers of Covid vaccines ... will review this decision and make necessary changes,” CEO Mary Holland said in a post on the group’s website.